Comparison of hs-cTnI, hs-cTnT, hFABP and GPBB for identifying early adverse cardiac events in patients presenting within six hours of chest pain-onset

Clinica Chimica Acta

Volumn 419, Issue , 2013, Pages 39-41

  Shortt, Colleen R ^a   Worster, Andrew ^a   Hill, Stephen A ^a   Kavsak, Peter A ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FATTY ACID BINDING PROTEIN; GLYCOGEN PHOSPHORYLASE; GLYCOGEN PHOSPHORYLASE BB; TROPONIN I; TROPONIN T; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ADULT; AREA UNDER THE CURVE; COHORT ANALYSIS; CONTROLLED STUDY; DEATH; DELONG CLARKE PEARSON METHOD; DIAGNOSTIC TEST ACCURACY STUDY; EMERGENCY WARD; FALSE POSITIVE RESULT; FEMALE; GERMANY; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; LETTER; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; ONSET AGE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; SYMPTOMATOLOGY; THORAX PAIN;

CHEST PAIN; FATTY ACID-BINDING PROTEINS; GLYCOGEN PHOSPHORYLASE; HUMANS; MYOCARDIAL INFARCTION; TIME FACTORS; TROPONIN I; TROPONIN T;

EID: 84874389159     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2013.01.008     Document Type: Letter

References (10)

1. Eggers K.M., Venge P., Lindahl B. High-sensitivity cardiac troponin T outperforms novel diagnostic biomarkers in patients with acute chest pain. Clin Chim Acta 2012, 413:1135-1140.
2. Lillpopp L., Tzikas S., Ojeda F., et al. Prognostic information of glycogen phosphorylase isoenzyme BB in patients with suspected acute coronary syndrome. Am J Cardiol 2012, 110:1225-1230.
3. Jaffe A.S. Third universal definition of myocardial infarction. Clin Biochem 2013, 46:1-4.
4. McMahon C.G., Lamont J.V., Curtin E., et al. Diagnostic accuracy of heart-type fatty acid-binding protein for the early diagnosis of acute myocardial infarction. Am J Emerg Med 2012, 30:267-274.
5. Worster A., Devereaux P.J., Heels-Ansdell D., et al. Capability of ischemia-modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome. CMAJ 2005, 172:1685-1690.
6. Kavsak P.A., Hill S.A., Bhanich Supapol W., Devereaux P.J., Worster A. Biomarkers for predicting serious cardiac outcomes at 72hours in patients presenting early after chest pain onset with symptoms of acute coronary syndromes. Clin Chem 2012, 58:298-302.
7. Apple F.S., Ler R., Murakami M.M. Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem 2012, 58:1574-1581.
8. Kavsak P.A., Xu L., Yusuf S., McQueen M.J. High-sensitivity cardiac troponin I measurement for risk stratification in a stable high-risk population. Clin Chem 2011, 57:1146-1153.
9. McQueen M.J., Kavsak P.A., Xu L., Shestakovska O., Yusuf S. Predicting myocardial infarction and other serious cardiac outcomes using high-sensitivity cardiac troponin T in a high-risk stable population. Clin Biochem 2013, 46:5-9.
10. Dong S.Y., Sun X.N., Zeng Q., Xu Y., Sun J., Ma L.H. Proteomic analysis of adverse outcomes in patients with acute coronary syndromes. Clin Chim Acta Nov 27 2012, 416C:60-66. 10.1016/j.cca.2012.11.019.